Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W W Overwijk

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Current Protocols in Immunology|April 25, 2008
B16 as a mouse model for human melanomaW W Overwijk, N P Restifo
Critical Reviews in Immunology|June 9, 2001
Autoimmunity and the immunotherapy of cancer: targeting the "self" to destroy the "other"W W Overwijk, N P Restifo
Trends in Immunology|April 5, 2001
Creating therapeutic cancer vaccines: notes from the battlefieldW W Overwijk, N P Restifo
The Cancer Journal From Scientific American|February 24, 2000
The future of interleukin-2: enhancing therapeutic anticancer vaccinesW W Overwijk, M R Theoret, N P Restifo
Methods (San Diego, Calif.)|June 1, 1997
Identification of a Kb-restricted CTL epitope of beta-galactosidase: potential use in development of immunization protocols for "self" antigensW W Overwijk, D R Surman, K Tsung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2000
Cutting edge: CD4+ T cell control of CD8+ T cell reactivity to a model tumor antigenD R Surman, M E Dudley, W W Overwijk, et al.
Journal of the National Cancer Institute|December 23, 1998
Construction and characterization of a triple-recombinant vaccinia virus encoding B7-1, interleukin 12, and a model tumor antigenM W Carroll, W W Overwijk, D R Surman, et al.
Vaccine|March 1, 1997
Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a murine tumor modelM W Carroll, W W Overwijk, R S Chamberlain, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1998
Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+ cellsV Bronte, M Wang, W W Overwijk, et al.
Cancer Research|February 10, 2000
Genetic vaccination with "self" tyrosinase-related protein 2 causes melanoma eradication but not vitiligoV Bronte, E Apolloni, R Ronca, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Current Protocols in Immunology|April 25, 2008
B16 as a mouse model for human melanomaW W Overwijk, N P Restifo
Critical Reviews in Immunology|June 9, 2001
Autoimmunity and the immunotherapy of cancer: targeting the "self" to destroy the "other"W W Overwijk, N P Restifo
Trends in Immunology|April 5, 2001
Creating therapeutic cancer vaccines: notes from the battlefieldW W Overwijk, N P Restifo
The Cancer Journal From Scientific American|February 24, 2000
The future of interleukin-2: enhancing therapeutic anticancer vaccinesW W Overwijk, M R Theoret, N P Restifo
Methods (San Diego, Calif.)|June 1, 1997
Identification of a Kb-restricted CTL epitope of beta-galactosidase: potential use in development of immunization protocols for "self" antigensW W Overwijk, D R Surman, K Tsung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2000
Cutting edge: CD4+ T cell control of CD8+ T cell reactivity to a model tumor antigenD R Surman, M E Dudley, W W Overwijk, et al.
Journal of the National Cancer Institute|December 23, 1998
Construction and characterization of a triple-recombinant vaccinia virus encoding B7-1, interleukin 12, and a model tumor antigenM W Carroll, W W Overwijk, D R Surman, et al.
Vaccine|March 1, 1997
Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a murine tumor modelM W Carroll, W W Overwijk, R S Chamberlain, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1998
Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+ cellsV Bronte, M Wang, W W Overwijk, et al.
Cancer Research|February 10, 2000
Genetic vaccination with "self" tyrosinase-related protein 2 causes melanoma eradication but not vitiligoV Bronte, E Apolloni, R Ronca, et al.
Pageof 3